Neil Belloff
Algemeen Adviseur bij ACORDA THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Neil S.
Belloff is currently the Secretary & General Counsel at Acorda Therapeutics, Inc. He previously worked as the Senior Corporate Counsel at Celgene Corp.
and as the Executive VP, US Corporate & Securities Counsel at Deutsche Telekom AG.
From 2020 to 2021, he served as the COO, Secretary, EVP & General Counsel at Eloxx Pharmaceuticals, Inc. Mr. Belloff completed his undergraduate studies at Queens College and his graduate studies at New York University.
He also obtained a graduate degree from Quinnipiac University School of Law.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
25-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Neil Belloff
Bedrijven | Functie | Begin |
---|---|---|
ACORDA THERAPEUTICS, INC. | Algemeen Adviseur | 08-11-2021 |
Eerdere bekende functies van Neil Belloff
Bedrijven | Functie | Einde |
---|---|---|
ELOXX PHARMACEUTICALS, INC. | Operationeel Directeur | 25-08-2021 |
CELGENE | Corporate Officer/Principal | - |
DEUTSCHE TELEKOM AG | Corporate Officer/Principal | - |
Opleiding van Neil Belloff
Quinnipiac University School of Law | Graduate Degree |
New York University | Graduate Degree |
Queens College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ELOXX PHARMACEUTICALS, INC. | Health Technology |
DEUTSCHE TELEKOM AG | Communications |
ACORDA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |